论文部分内容阅读
目的探讨分析脑苷肌肽联合醒脑静注射液治疗脑梗死的临床疗效。方法 150例脑梗死患者,根据随机数字表法分为观察组与对照组,每组75例。观察组患者给予脑苷肌肽注射液联合醒脑静注射液治疗,对照组患者给予胞二磷胆碱注射液联合血塞通注射液治疗。比较两组的治疗效果。结果观察组总有效率为96.0%,高于对照组的85.3%,差异具有统计学意义(P<0.05)。结论脑苷肌肽联合醒脑静注射液治疗脑梗死患者可有效提高患者的临床治疗效果,无明显药物不良反应,可在临床中推广。
Objective To investigate the clinical efficacy of brain glycosides combined with xingnaojing injection in treating cerebral infarction. Methods A total of 150 patients with cerebral infarction were divided into observation group and control group according to the random number table method, with 75 cases in each group. Patients in the observation group were given intracerebroventricular injection combined with xingnaojing injection, and patients in the control group were treated with citicoline injection combined with Xuesaitong injection. Compare the treatment effect of two groups. Results The total effective rate in observation group was 96.0%, which was higher than that in control group (85.3%), the difference was statistically significant (P <0.05). Conclusion Cerebroside combined with xingnaojing injection in patients with cerebral infarction can effectively improve the clinical effect of patients without obvious adverse drug reactions, which can be promoted in clinic.